2
Clinical Trials associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Changsheng)随机、双盲、阳性对照评价流感病毒裂解疫苗(四价)在6月龄至35月龄人群中免疫原性和安全性的Ⅲ期临床试验
[Translation] A randomized, double-blind, positive-controlled phase III clinical trial to evaluate the immunogenicity and safety of influenza virus split vaccine (quadrivalent) in people aged 6 to 35 months
Ⅰ期研究初步评价流感病毒裂解疫苗(四价)的安全性,Ⅲ期研究进行扩大规模的人群试验,评价流感病毒裂解疫苗(四价)的免疫原性和安全性。
[Translation] The Phase I study preliminarily evaluated the safety of the influenza virus split vaccine (quadrivalent), and the Phase III study conducted an expanded population trial to evaluate the immunogenicity and safety of the influenza virus split vaccine (quadrivalent).
评价流感病毒裂解疫苗(四价)在3岁以上健康人群中接种的安全性和免疫原性
[Translation] To evaluate the safety and immunogenicity of influenza virus split vaccine (quadrivalent) in healthy people aged 3 years and above
Ⅰ期研究初步评价流感病毒裂解疫苗(四价)的安全性;Ⅲ期研究进行扩大规模的人群试验,评价流感病毒裂解疫苗(四价)的免疫原性和安全性
[Translation] Phase I study preliminarily evaluates the safety of influenza virus split vaccine (quadrivalent); Phase III study conducts a large-scale population trial to evaluate the immunogenicity and safety of influenza virus split vaccine (quadrivalent)
100 Clinical Results associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Changsheng)
100 Translational Medicine associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Changsheng)
100 Patents (Medical) associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Changsheng)
100 Deals associated with Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Changsheng)